CIC
TNYA icon

Cornercap Investment Counsel’s Tenaya Therapeutics TNYA Stock Holding History

Cornercap Investment Counsel’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,222
Closed -$58.3K – 536
2024
Q3 		$58.3K Sell
30,222
-33,616
-53% -$94.9K 0.02% 504
2024
Q2 		$198K Sell
63,838
-725
-1% -$2.99K 0.03% 541
2024
Q1 		$338K Sell
64,563
-16,692
-21% -$79.9K 0.05% 507
2023
Q4 		$263K Buy
81,255
+46,847
+136% +$101K 0.04% 497
2023
Q3 		$87.7K Sell
34,408
-439
-1% -$1.84K 0.02% 538
2023
Q2 		$205K Buy
+34,847
New +$203K 0.04% 507

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Cornercap Investment Counsel's TNYA Position: Q4 2024 in Review

Cornercap Investment Counsel sold out of Tenaya Therapeutics (TNYA) in Q4 2024, closing a stake of 30,222 shares — an estimated $58.3K sold.

Cornercap Investment Counsel first reported a position in TNYA in Q2 2023 and held it in 6 quarters. The position peaked at $338K in Q1 2024. 88 funds tracked by Wall St. Rank hold TNYA as of Q4 2024.

  • Cornercap Investment Counsel reported no remaining Tenaya Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 30,222 Tenaya Therapeutics shares in Q4 2024, an estimated $58.3K.
  • Cornercap Investment Counsel first reported a position in Tenaya Therapeutics in Q2 2023 and held it in 6 quarters.
  • Cornercap Investment Counsel's Tenaya Therapeutics position peaked at $338K in Q1 2024.
  • 88 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q4 2024.

Based on Cornercap Investment Counsel's 13F filing for Q4 2024, filed 12 Feb 2025.